These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11716878)

  • 1. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
    Burke RE
    Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Parkinson's disease.
    Polymeropoulos MH
    Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
    [No Abstract]   [Full Text] [Related]  

  • 5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
    Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
    Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
    Baptista MJ; Cookson MR; Miller DW
    Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Parkinson's disease. Alpha-synuclein and parkin.
    Mizuno Y; Hattori N; Kitada T; Matsumine H; Mori H; Shimura H; Kubo S; Kobayashi H; Asakawa S; Minoshima S; Shimizu N
    Adv Neurol; 2001; 86():13-21. PubMed ID: 11553970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex interactions in Parkinson's disease: a two-phased approach.
    Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular pathogenesis of familial Parkinson's disease].
    Kitada T; Mizuno Y
    Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland.
    Autere JM; Hiltunen MJ; Mannermaa AJ; Jäkälä PA; Hartikainen PH; Majamaa K; Alafuzoff I; Soininen HS
    Eur J Neurol; 2002 Sep; 9(5):479-83. PubMed ID: 12220378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
    Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
    Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
    Goldberg MS; Lansbury PT
    Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
    Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
    Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: alpha-synuclein and parkin in protein aggregation and the reversal of unfolded protein stress.
    Jakobsen LD; Jensen PH
    Methods Mol Biol; 2003; 232():57-66. PubMed ID: 12840539
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.